Camatche, Dexy Jill B.

HRN: 23-06-52  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/18/2023
AMPICILLIN 1GM (VIAL)
05/18/2023
05/25/2023
IV
2g
Q6
PROM X 16 Hours; G1P0 39 3/7 Weeks AOG By LMP; Young Primigravid
Checking Final Appropriateness 

Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Intervention



Type of Intervention done:

                    

           


Acceptance: